novo nordisk new glp 1 promotes GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article Oral GLP-1 Wegovy chases approval

Newer medications like tirzepatide generally cost more than established options such as liraglutide

This illustration stands out with its clean lines and energetic feel, perfectly matching the vibe of a transformative summer

Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-Year matched cohort study

Figures were generated and adapted using Microsoft PowerPoint and BioRender, based on data synthesized from the reviewed studies

To report side effects, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch

You can usually find this on your BCBS companys website or by logging into your account